Cargando…
COVID-19–Specific Strategies for the Treatment of ST-Segment Elevation Myocardial Infarction in China
[Figure: see text]
Autores principales: | Ranard, Lauren S., Parikh, Sahil A., Kirtane, Ajay J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American College of Cardiology Foundation. Published by Elsevier.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428312/ https://www.ncbi.nlm.nih.gov/pubmed/32807587 http://dx.doi.org/10.1016/j.jacc.2020.07.054 |
Ejemplares similares
-
Anemia and Inflammation in ST-Segment Elevation Myocardial Infarction
por: Zhang, Enyuan, et al.
Publicado: (2015) -
High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction
por: Choudry, Fizzah A., et al.
Publicado: (2020) -
Mortality in ST-Segment Elevation Myocardial Infarction With Nonobstructive Coronary Arteries and Mimickers
por: Quesada, Odayme, et al.
Publicado: (2023) -
Ticagrelor or clopidogrel dual antiplatelet therapy following a pharmacoinvasive strategy in ST‐segment elevation myocardial infarction
por: Welsh, Robert C., et al.
Publicado: (2021) -
Prognostic value of admission electrocardiographic findings in non‐ST‐segment elevation myocardial infarction
por: Chen, Peng‐fei, et al.
Publicado: (2020)